Pulmonx
Denis Daligault is a seasoned professional in the medical device and pharmaceutical industries, currently serving as the Territory Manager for Pulmonx Corporation since November 2019, specializing in the promotion of the Valve Zephyr for emphysema patients. With experience as a Territory Manager in Pulmonary Endoscopy at Boston Scientific since November 2016, Denis has honed skills in developing medical devices within interventional pulmonology. Previous roles include Account Manager at Abbott Point of Care, Regional Sales Manager at Roche Diagnostics Diabete, and various sales positions at BECTON DICKINSON and MOLNLYCKE HEALTH CARE, where Denis demonstrated success in sales strategy, account management, and team leadership. Beginning a career as a Medical Representative at SERVIER LABORATORY, Denis possesses a comprehensive background in building relationships with healthcare professionals and driving market growth. An educational foundation in marketing and sales further complements Denis's extensive industry experience.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1